Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halperin

Showing results (501-510 of 544) with videos related to

Pageof 55
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteersShelly A McNeil, Scott A Halperin, Joanne M Langley, et al.
Vaccine|April 24, 2012
Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety dataJane F Gidudu, Gary A Walco, Anna Taddio, et al.
Human Vaccines & Immunotherapeutics|January 8, 2025
Considering the impact of vaccine communication in the COVID-19 pandemic among adults in Canada: A qualitative study of lessons learned for future vaccine campaignsJeanna Parsons Leigh, Stephana Julia Moss, Jade MacDonald, et al.
CMAJ Open|April 14, 2021
Obstetric and perinatal health outcomes after pertussis vaccination during pregnancy in Ontario, Canada: a retrospective cohort studyRomina Fakhraei, Natasha Crowcroft, Shelly Bolotin, et al.
Journal of Clinical Epidemiology|November 26, 2025
The Risk of Bias in Vaccine Effectiveness (RoB-VE) project: introduction to a methodological initiative to improve risk-of-bias assessment and reporting in vaccine effectiveness researchCassandra Laurie, Pablo Alonso Coello, Ivan D Florez, et al.
Vaccine|February 14, 2012
Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of ageScott A Halperin, Brian Ward, Curtis Cooper, et al.
CMAJ Open|February 3, 2023
Trends and characteristics of Tdap vaccination during pregnancy in Ontario, Canada: a retrospective cohort studyRomina Fakhraei, Stephen G Fung, William Petrcich, et al.
Vaccine|August 12, 2025
Knowledge gaps and research priorities regarding vaccination in pregnancy: A Canadian perspective from the prevention of infections in the maternal-infant dyad (PRIMED) consortiumOlivia F Hunter, Elisabeth McClymont, Oscar Lau, et al.
Plos One|August 19, 2024
Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) studyJames Wright, Natasha Crowcroft, Elizabeth McLachlan, et al.
The Pediatric Infectious Disease Journal|September 15, 2016
Immunizing Patients With Adverse Events After Immunization and Potential Contraindications to Immunization: A Report From the Special Immunization Clinics NetworkKarina A Top, Marie-Noelle Billard, Marie-Claude Gariepy, et al.
Pageof 55

Showing results (501-510 of 544) with videos related to

Sort By:
Pageof 55
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteersShelly A McNeil, Scott A Halperin, Joanne M Langley, et al.
Vaccine|April 24, 2012
Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety dataJane F Gidudu, Gary A Walco, Anna Taddio, et al.
Human Vaccines & Immunotherapeutics|January 8, 2025
Considering the impact of vaccine communication in the COVID-19 pandemic among adults in Canada: A qualitative study of lessons learned for future vaccine campaignsJeanna Parsons Leigh, Stephana Julia Moss, Jade MacDonald, et al.
CMAJ Open|April 14, 2021
Obstetric and perinatal health outcomes after pertussis vaccination during pregnancy in Ontario, Canada: a retrospective cohort studyRomina Fakhraei, Natasha Crowcroft, Shelly Bolotin, et al.
Journal of Clinical Epidemiology|November 26, 2025
The Risk of Bias in Vaccine Effectiveness (RoB-VE) project: introduction to a methodological initiative to improve risk-of-bias assessment and reporting in vaccine effectiveness researchCassandra Laurie, Pablo Alonso Coello, Ivan D Florez, et al.
Vaccine|February 14, 2012
Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of ageScott A Halperin, Brian Ward, Curtis Cooper, et al.
CMAJ Open|February 3, 2023
Trends and characteristics of Tdap vaccination during pregnancy in Ontario, Canada: a retrospective cohort studyRomina Fakhraei, Stephen G Fung, William Petrcich, et al.
Vaccine|August 12, 2025
Knowledge gaps and research priorities regarding vaccination in pregnancy: A Canadian perspective from the prevention of infections in the maternal-infant dyad (PRIMED) consortiumOlivia F Hunter, Elisabeth McClymont, Oscar Lau, et al.
Plos One|August 19, 2024
Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) studyJames Wright, Natasha Crowcroft, Elizabeth McLachlan, et al.
The Pediatric Infectious Disease Journal|September 15, 2016
Immunizing Patients With Adverse Events After Immunization and Potential Contraindications to Immunization: A Report From the Special Immunization Clinics NetworkKarina A Top, Marie-Noelle Billard, Marie-Claude Gariepy, et al.
Pageof 55